Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 1/2014

Open Access 01-12-2014 | Poster presentation

PB.39. CT or not CT: a systematic review of the breast on CT of the chest and abdomen over 1 year - another screening tool?

Authors: S Flais, A Newland, A Flais, B Ellis

Published in: Breast Cancer Research | Special Issue 1/2014

Login to get access

Excerpt

Images of breast tissue are usually included on CT scans of the chest or abdomen. It is generally thought that CT has a low sensitivity for breast pathology. We tested this assumption to assess the importance of the breast as a review area on CT. …
Metadata
Title
PB.39. CT or not CT: a systematic review of the breast on CT of the chest and abdomen over 1 year - another screening tool?
Authors
S Flais
A Newland
A Flais
B Ellis
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 1/2014
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr3725

Other articles of this Special Issue 1/2014

Breast Cancer Research 1/2014 Go to the issue

Poster presentation

PB.31. Occult breast carcinoma: an experience at a single unit

Poster presentation

PB.30. Apparent diffusion coefficient and fractional anisotropy values as biomarkers for treatment response in breast cancer

Poster presentation

PB.3. Detection of lymph node metastases in newly diagnosed breast cancer patients with axillary ultrasonography in combination with the Memorial Sloan Kettering Cancer Centre normogram as a prediction tool

Poster presentation

PB.7. Large-volume biopsy for B3 lesions without atypia: is once enough?

Poster presentation

PB.6. Management of radial scars on core biopsy

Poster presentation

PB.15. An audit of our benign surgical biopsy rate in the prevalent round for the reporting year 1 April 2012 to 31 March 2013
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits